{"id":21468,"date":"2022-05-26T09:08:37","date_gmt":"2022-05-26T07:08:37","guid":{"rendered":"https:\/\/idibell.cat\/?p=21468"},"modified":"2022-05-26T09:08:54","modified_gmt":"2022-05-26T07:08:54","slug":"la-spin-off-sorgida-de-lidibell-aptadel-therapeutics-rep-lajuda-europea-eurostars","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2022\/05\/la-spin-off-sorgida-de-lidibell-aptadel-therapeutics-rep-lajuda-europea-eurostars\/","title":{"rendered":"La spin-off sorgida de l’IDIBELL Aptadel Therapeutics rep l’ajuda europea Eurostars"},"content":{"rendered":"
Aptadel Therapeutics ha rebut una beca europea Eurostars<\/strong> per a desenvolupar la primera ter\u00e0pia dirigida contra el c\u00e0ncer infantil Sarcoma d’Ewing, basada en nanopart\u00edcules d’ARN.<\/p>\n El Sarcoma d’Ewing<\/strong> \u00e9s un tipus rar de tumor cancer\u00f3s que creix als ossos o als teixits tous. Afecta principalment nens i joves, per\u00f2 tamb\u00e9 s’observa en adults. Aquests tumors s\u00f3n molt agressius, tendeixen a reapar\u00e8ixer i desenvolupar met\u00e0stasi despr\u00e9s de la quimioter\u00e0pia. Es tracta del segon c\u00e0ncer d’os primari m\u00e9s diagnosticat entre nens i adults joves. A causa de la manca de tractaments efectius, la superviv\u00e8ncia dels pacients amb sarcoma pedi\u00e0tric que presenten met\u00e0stasi en el moment del diagn\u00f2stic \u00e9s amb prou feines del 20%.<\/p>\n Aptadel Therapeutics<\/strong> \u00e9s una empresa precl\u00ednica cofundada per l’IDIBELL enfocada a desenvolupar una nova plataforma de ter\u00e0pia dirigida contra el c\u00e0ncer. Aquesta plataforma consisteix en nanopart\u00edcules carregades amb agents terap\u00e8utics, com poden ser mol\u00e8cules d’ARN o f\u00e0rmacs quimioter\u00e0pics, dirigides a diferents tumors diana. D’aquesta manera els agents terap\u00e8utics s\u00f3n alliberats nom\u00e9s all\u00e0 on fa falta, evitant aix\u00ed efectes secundaris i millorant l’efectivitat de les ter\u00e0pies. En concret, aquesta ajuda anir\u00e0 dirigida a desenvolupar un tractament dirigit al receptor EphA2, reduint aix\u00ed la capacitat de met\u00e0stasi de les c\u00e8l\u00b7lules canceroses.<\/p>\n El Dr. \u00d3scar Mart\u00ednez-Tirado<\/strong>, investigador de l’IDIBELL i cofundador de la spin-off, apunta que: “Estem molt emocionats d’haver rebut una subvenci\u00f3 tan competitiva. El projecte Eurostars impulsar\u00e0 el desenvolupament del primer actiu d’Aptadel a la cl\u00ednica per tractar el c\u00e0ncer pedi\u00e0tric<\/em>“.<\/p>\n <\/p>\n <\/p>\n L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" Aquesta ajuda anir\u00e0 dirigida a desenvolupar un tractament dirigit basat en nanopart\u00edcules per al c\u00e0ncer pedi\u00e0tric Sarcoma d’Ewing.<\/p>\n","protected":false},"author":8,"featured_media":21469,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[493],"tags":[],"class_list":["post-21468","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovacio"],"publishpress_future_action":{"enabled":false,"date":"2024-12-25 10:33:21","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/21468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=21468"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/21468\/revisions"}],"predecessor-version":[{"id":21470,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/21468\/revisions\/21470"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/21469"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=21468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=21468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=21468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}